is a senior associate in Clifford Chance's litigation and dispute resolution group. Highlights of his experience include acting for Pfizer in its successful appeal to the CAT, which set aside the CMA's excessive pricing decision (now before the Court of Appeal).
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.